Canada Life’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $40K | Sell |
8,914
-71,287
| -89% | -$371K | ﹤0.01% | 1782 |
|
|
2025
Q4 | $493K | Sell |
80,201
-6,367
| -7% | -$46.2K | ﹤0.01% | 1510 |
|
|
2025
Q3 | $625K | Buy |
86,568
+1,346
| +2% | +$7.99K | ﹤0.01% | 1560 |
|
|
2025
Q2 | $452K | Sell |
85,222
-9,931
| -10% | -$58.7K | ﹤0.01% | 1629 |
|
|
2025
Q1 | $845K | Sell |
95,153
-14,825
| -13% | -$178K | ﹤0.01% | 1482 |
|
|
2024
Q4 | $1.51M | Sell |
109,978
-700
| -0.6% | -$12.9K | ﹤0.01% | 1361 |
|
|
2024
Q3 | $3.03M | Sell |
110,678
-3,355
| -3% | -$90.8K | 0.01% | 1112 |
|
|
2024
Q2 | $2.79M | Buy |
114,033
+10,535
| +10% | +$231K | 0.01% | 1114 |
|
|
2024
Q1 | $2.2M | Buy |
103,498
+7,123
| +7% | +$153K | ﹤0.01% | 1199 |
|
|
2023
Q4 | $1.84M | Buy |
96,375
+1,276
| +1% | +$22.1K | ﹤0.01% | 1285 |
|
|
2023
Q3 | $1.52M | Sell |
95,099
-56
| -0.1% | -$1.07K | ﹤0.01% | 1336 |
|
|
2023
Q2 | $2.21M | Sell |
95,155
-3,134
| -3% | -$68.4K | 0.01% | 1148 |
|
|
2023
Q1 | $2.28M | Sell |
98,289
-6,026
| -6% | -$122K | 0.01% | 1163 |
|
|
2022
Q4 | $1.51M | Buy |
104,315
+2,249
| +2% | +$41.9K | ﹤0.01% | 1365 |
|
|
2022
Q3 | $1.95M | Buy |
102,066
+20,219
| +25% | +$464K | 0.01% | 1194 |
|
|
2022
Q2 | $1.49M | Buy |
81,847
+10,153
| +14% | +$211K | ﹤0.01% | 1296 |
|
|
2022
Q1 | $1.85M | Buy |
71,694
+1,711
| +2% | +$43.8K | ﹤0.01% | 1239 |
|
|
2021
Q4 | $1.93M | Buy |
69,983
+2,414
| +4% | +$69.9K | ﹤0.01% | 1217 |
|
|
2021
Q3 | $2.2M | Sell |
67,569
-377
| -0.6% | -$12.5K | 0.01% | 1121 |
|
|
2021
Q2 | $2.07M | Buy |
67,946
+1,399
| +2% | +$40.4K | ﹤0.01% | 1131 |
|
|
2021
Q1 | $2.03M | Sell |
66,547
-8,521
| -11% | -$242K | ﹤0.01% | 1138 |
|
|
2020
Q4 | $1.48M | Sell |
75,068
-10,959
| -13% | -$177K | ﹤0.01% | 1309 |
|
|
2020
Q3 | $1.12M | Sell |
86,027
-8,462
| -9% | -$107K | ﹤0.01% | 1362 |
|
|
2020
Q2 | $1.07M | Sell |
94,489
-5,846
| -6% | -$83K | ﹤0.01% | 1411 |
|
|
2020
Q1 | $1.43M | Buy |
100,335
+6,942
| +7% | +$147K | ﹤0.01% | 1116 |
|
|
2019
Q4 | $2.52M | Buy |
+93,393
| New | +$2.57M | 0.01% | 993 |
|
|
2019
Q3 | – | Sell |
-97,224
| Closed | -$2.7M | – | 1838 |
|
|
2019
Q2 | $2.7M | Sell |
97,224
-1,157
| -1% | -$32.7K | 0.01% | 992 |
|
|
2019
Q1 | $3.26M | Sell |
98,381
-761
| -0.8% | -$23.2K | 0.01% | 794 |
|
|
2018
Q4 | $2.66M | Buy |
99,142
+9,944
| +11% | +$358K | 0.01% | 869 |
|
|
2018
Q3 | $4.1M | Sell |
89,198
-2,184
| -2% | -$97.1K | 0.01% | 776 |
|
|
2018
Q2 | $3.41M | Sell |
91,382
-1,378
| -1% | -$46.5K | 0.01% | 855 |
|
|
2018
Q1 | $2.74M | Buy |
92,760
+1,858
| +2% | +$62.9K | 0.01% | 953 |
|
|
2017
Q4 | $3.12M | Sell |
90,902
-3,984
| -4% | -$134K | 0.01% | 891 |
|
|
2017
Q3 | $3.43M | Sell |
94,886
-5,808
| -6% | -$166K | 0.01% | 831 |
|
|
2017
Q2 | $2.6M | Buy |
100,694
+3,180
| +3% | +$67.5K | 0.01% | 962 |
|
|
2017
Q1 | $1.87M | Buy |
97,514
+88,301
| +958% | +$1.56M | 0.01% | 1183 |
|
|
2016
Q4 | $154K | Hold |
9,213
| – | – | ﹤0.01% | 1983 |
|
|
2016
Q3 | $189K | Hold |
9,213
| – | – | ﹤0.01% | 1919 |
|
|
2016
Q2 | $281K | Hold |
9,213
| – | – | ﹤0.01% | 1799 |
|
|
2016
Q1 | $345K | Buy |
9,213
+2,674
| +41% | +$101K | ﹤0.01% | 1033 |
|
|
2015
Q4 | $282K | Hold |
6,539
| – | – | ﹤0.01% | 1101 |
|
|
2015
Q3 | $246K | Hold |
6,539
| – | – | ﹤0.01% | 1141 |
|
|
2015
Q2 | $222K | Hold |
6,539
| – | – | ﹤0.01% | 1324 |
|
|
2015
Q1 | $231K | Buy |
6,539
+1,979
| +43% | +$70.8K | ﹤0.01% | 1274 |
|
|
2014
Q4 | $155K | Hold |
4,560
| – | – | ﹤0.01% | 1452 |
|
|
2014
Q3 | $177K | Sell |
4,560
-36
| -0.8% | -$1.34K | ﹤0.01% | 1288 |
|
|
2014
Q2 | $178K | Buy |
4,596
+36
| +0.8% | +$1.34K | ﹤0.01% | 1200 |
|
|
2014
Q1 | $155K | Hold |
4,560
| – | – | ﹤0.01% | 1220 |
|
|
2013
Q4 | $96K | Buy |
+4,560
| New | +$115K | ﹤0.01% | 1430 |
|
Other funds holding MYGN
O
GCM
VCM
VPM
Canada Life's MYGN Position: Q1 2026 in Review
Canada Life reduced its Myriad Genetics (MYGN) stake by 89% in Q1 2026, selling an estimated $371K and leaving 8,914 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #1782.
Canada Life first reported a position in MYGN in Q4 2013 and has held it in 49 quarters since. The position peaked at $4.1M in Q3 2018. 202 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.
- Canada Life held 8,914 shares of Myriad Genetics worth $40K as of Q1 2026.
- Canada Life sold 71,287 Myriad Genetics shares in Q1 2026, an estimated $371K.
- Myriad Genetics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1782 holding.
- Canada Life first reported a position in Myriad Genetics in Q4 2013 and has held it in 49 quarters since.
- Canada Life's Myriad Genetics position peaked at $4.1M in Q3 2018.
- 202 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.